Frost.com - Healthcare Research http://www.frost.com/c/10024/home.do - Healthcare Research Mon, 20 Feb 2017 20:31:46 Medical Device Innovations in Bionics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0E-00-00 Bionics refers to cutting-edge electromechanical systems that are used to mimic biological systems, in order to support, augment or elevate their functional output. The latest issue of the Medical Device TOE profiles innovations in bionic systems and their application in orthopedics, cognitive function, vision improvement, and in the restoration of sensory function to limbs. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Bionics, neuroprosthetics, robotic exoskeleton, human enablement, brain-computer interface Fri, 17 Feb 2017 00:00:00 +0000 Advances in Gene Therapy for the Management of Neurodegenerative Diseases http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-3A-00-00 This Genetic Technology TOE depicts recent advances in gene therapy for the management of neurodegenerative diseases. Genetic technology advances are likely to open novel avenues across gene therapy for management of neurodegenerative diseases. This study focusses on some important innovations in the field. The corresponding clinical trial scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Cholesterol metabolism, Huntington s disease, Alzheimer s Disease, Parkinson s disease, gene therapy, cholesterol metabolism, retromers, neurodegenerative diseases, aromatic l-amino acid decarboxylase targets, telomerase gene therapy Fri, 17 Feb 2017 00:00:00 +0000 Global Healthcare Industry Outlook, 2017 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K152-01-00-00-00 In this research deliverable, Frost & Sullivan s senior analyst team provides bold perspectives and predictions for the global healthcare industry in 2017. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical devices, medical imaging, and healthcare IT. The analysis captures the impact of trends that are expected to transpire over the upcoming year as organizations shift to prepare for the future. This study provides guidance on where to find the greatest opportunities for expansion. Despite global political uncertainties and a sluggish economic outlook, 2017 will be an amped-up year for the global healthcare industry that promises partial realization of major health policies and initiatives. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g., China, India, Brazil) which demonstrate high growth opportunities compared against saturated developed markets in the Western hemisphere. For instance, in the United States and Western Europe, 2017 will be a tipping point for mainstream adoption of popular digital health solutions such as wearables and telehealth as well as a transition phase of noble technologies from research to actionable clinical applications (e.g., diagnostic tools, artificial intelligence, blockchain). The outlook foresees increased collaboration and M&A activities between the life sciences and medical device industries, in which product designs will support prevention of the onset of chronic and degenerative diseases. Key Predictions for 2017 Total Healthcare Industry Include: Action Taken on Prescription Drug Price Inflation A strong push will occur towards price control and transparency measures around drugs. Phase 2 of Value-based Care Deployment - Countries spending >10% of their GDP on healthcare will have more impetus for value-based care. Tech Companies Get Serious About Healthcare - 2017 will mark a tangible shift for tech companies such as Apple, Google, and IBM towards more clinical-oriented solutions. Healthcare Investment to have a Record Year - Confluence of events is poised to make 2017 a banner year for VC investment in healthcare. Digital Transformation Modernizes Behavioral Health Treatment - Behavioral therapies will emerge as efficient alternatives in post-care settings and rehabilitation centers. Novel Point-of-care-testing (POCT) Tools Push Telehealth beyond Video Conferencing The global POCT market is poised to reach over $10.5 billion during 2017. Consumer the New King in Healthcare Decision Making Consumers become top influencers in healthcare decision making. Blockchain Technologies into the Healthcare World - Blockchain will become one of the most important technologies in the healthcare space. Key Questions This Study Will Answer: What are the top healthcare market predictions for 2017? What will the market revenue and growth rate look like for the global healthcare industry? What are the key projections and trends for major healthcare market segments? What are the major macro and micro regional/country-level trends specific to the healthcare industry? What are the key technologies and trends to watch for during 2017? Thu, 16 Feb 2017 00:00:00 +0000 Recent Advances in Cancer Genetics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-39-00-00 This Genetic Technology TOE depicts trends across cancer genetics. Constituting a genetic disorder in which the normal control of cell growth is significantly altered, cancer disease represents one of the most globally concerned fields of research. Cancer treatment and diagnostics may find a new hope in cancer genetics, which explains the rapid expansion of this discipline across medical specialties. The corresponding clinical trial analysis is depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Genomic companion diagnostic platform, companion diagnostics, prostate cancer, checkpoint inhibitor therapy, human fibroblasts, neural stem cell-based therapy, epigenetics, Ewing sarcoma Fri, 10 Feb 2017 00:00:00 +0000 Non-opioids Solutions for Cancer Treatment and Pain Management http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0E-00-00 Marine-derived pharmaceuticals have been used as sources of providing a range of chemical diversity in drug discovery. Marine-derived pharmaceuticals are the outcome of a breakthrough application of biotechnology. They enable producing therapeutic agents that could ultimately be used by the medical community to combat life-threatening illnesses. The sudden increase in the utilization of marine-derived pharmaceutical products can be directly linked to the uptake of research activities in this space. These marine derived pharmaceutical products require a significant amount of basic and applied research, so that they can be compared in terms of efficacy and safety and quality to patented pharmaceutical products that are in the market. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Marine-derived pharmaceuticals, chemical diversity, marine biotechnology, pharmaceutical potential, marine organism Fri, 10 Feb 2017 00:00:00 +0000 Developments in Neuromodulation Therapies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D835-00-17-00-00 This edition of FT TOE covers technological developments and commercial implications of various neuromodulation therapies that are redefining the standard of care offered by traditional drug-based therapies. The issue covers a snapshot of the global neuromodulation industry, highlighting the intensity of research and commercial prospects for newer clinical applications of these therapies. Detailed analysis of the market and technological drivers and challenges are covered, along with their influence on value of care offered to patients. The issue covers four innovation portfolios within this technology sector, including information and analyst insights on potential business models that could redefine healthcare. The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Neuromodulation therapies, deep brain stimulation, spinal cord stimulation, depression therapies Fri, 3 Feb 2017 00:00:00 +0000 Mobile Health and Telemedicine Markets in Brazil, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K08F-01-00-00-00 Brazil s telemedicine market is likely to increase from $495.3 million in 2015 to $743.8 million in 2017 whereas the mHealth market revenue will grow from $446.8 million to $1.43 billion over the same period. Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine applications encompass real-time solutions such as specialist consultation and distance learning/education. mHealth is a promising market with a broad range of applications including delivery through telemedicine. Nevertheless, it encounters several barriers to realizing the market potential. From wearables to apps, vital signs remote monitoring and chronic disease management, mHealth is constantly transforming the entire ecosystem with new value proposition and solutions. Digital health in Brazil offers huge opportunity given that industry convergence is transforming how care is delivered via the intersection between the healthcare and ICT industries. Forecast Segmentation: mHealth focus on chronic patient management, telecom counseling, wearables and connected devices, paid applications Telemedicine focus on tele-imaging and real-time telemedicine Research Scope: Telemedicine and mHealth products and services, including perspectives on current and future trends (findings discussed within the context of Frost & Sullivan s views regarding the telehealth industry in Brazil) Market introduction (definitions of scope, stage of mHealth and telemedicine, regulatory space) Market forecasts and trends for 2016 2020 (areas of growth opportunity near and long term, key drivers and restraints, novel business models) Market value chain (key stakeholders in both mHealth and telemedicine markets) Strategic imperatives (key requirements to succeed in the Brazilian marketplace going forward) Key Questions This Study Will Answer: What is the current stage of mHealth and telemedicine in Brazil? Which areas in mHealth and telemedicine provide growth opportunities in the near and long term? What are the key drivers and restraints impacting the mHealth and telemedicine markets? Who are the key stakeholders in Brazil that are part of the digital health value chain? What are the key requirements to succeed in the Brazilian marketplace going forward? The Brazilian telehealth market includes an array of health IT, tech, and communication technologies stakeholders who are stepping forward to be a part of a complex ecosystem of digital health where health data collection, curation, and effective utilization will be mandatory as the market evolves. While some areas are more limited than what is occurring elsewhere (e.g., North America), sectors such as teleradiology/tele-imaging and specialist services represent realized value opportunities that boost market revenue. It is essential for vendors to understand fully the Brazilian healthcare market and its inherent idiosyncrasies to optimize chances of success, especially if looking to enter from another country or region. This study provides readers an overview of the key market factors, drivers and restraints, and value chain activity specific to Brazil, including vendors throughout the ecosystem, company cases, and a insightful view of country s healthcare landscape. Fri, 3 Feb 2017 00:00:00 +0000 Recent Innovations in Healthcare, Electric Vehicles, Artificial Intelligence, and Food Packaging http://www.frost.com/prod/servlet/sublib/display-report.do?id=D707-00-38-00-00 This edition of the Inside R&D TOE depicts trends in a series of developments associated with innovations in healthcare, electric vehicles, artificial intelligence, and the food packaging industry. The TOE focuses on innovations in for skin cancer diagnosis using a software program and it also showcases advances in surgical instruments, which can view delicate blood vessels using infrared light. The TOE also emphasizes on automobile innovations such as development of advanced energy management system (EMS) mechanisms and food packaging innovations such as using biodegradable film packaging. It also provides information related to use of artificial intelligence- and machine learning-based software to spot and prevent child abuse in P2P networks and prevent it. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotive, power systems, sustainable energy solutions and innovations that contribute to a cleaner and greener environment. Keywords: Skin cancer, artificial intelligence, brain biopsies, hybrid electric vehicles, EMS for vehicles, child abuse prevention, food packaging, biodegradable film, nanocomposite films Fri, 3 Feb 2017 00:00:00 +0000 Recent Advances across Genetic Discoveries http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-38-00-00 With the increase in gene-based technologies such as gene regulation and gene editing, there have been a number of recent discovers across genetic technologies. Currently, there is keen interest toward developing novel treatments based on genes that have been discovered to have a major linkage to the development and progression of certain rare diseases. A prominent rare disease that is being actively researched is the Fragile X Syndrome. There are also a range of companies that have successfully utilized gene editing techniques to develop diseases resistance in mammalian species. Such gene editing techniques could revolutionize the manner in which human diseases can be cured in the near future. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Gene editing technique, gene regulation, genetic technologies, Fragile X Syndrome, rare genetic diseases, hybrid embryos, pig chimera, CRISPR Fri, 3 Feb 2017 00:00:00 +0000 Nanotechnology Aids in Effective Cancer Therapy http://www.frost.com/prod/servlet/sublib/display-report.do?id=D787-00-38-00-00 Researchers are leveraging nanotechnology by manipulating molecules and structures much smaller than a single cell to enhance the capability to monitor and destroy cancer cells in human body. New biocompatible materials that are highly sensitive and precise enough to destroy cancer cells without harming healthy cells are becoming a prime area of research focus. Research is also focused toward solutions that have superior targeting capabilities. Traditional cancer drugs are being replaced with technologies either with nanomaterials or nanoencapsulation to disintegrate the carcinogenic entity and/or destroy its nutritional support as a whole. The Nanotech TechVision Opportunity Engine (TOE) provides intelligence on technologies, products, processes, applications, and strategic insights on nanotechnology-related innovations and their impact across various industries. Technology focus areas include nanomaterials, nanocoatings, nanohealthcare, nanomedicine, and nanomanufacturing. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Carcinogenic, radiotherapy, oncology, selectivity Fri, 3 Feb 2017 00:00:00 +0000 Review of Key Medical Imaging and Informatics Market Trends from RSNA 2016 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297277239 Frost & Sullivan again attended the annual meeting of the Radiological society of North America (RSNA). Thu, 2 Feb 2017 00:00:00 +0000 Spain s New Business Models in Medical Imaging, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MBFB-01-00-00-00 Low economic growth and limited access to capital funding compel hospitals in Spain to adopt new purchasing and service models for imaging equipment. The drive to operationalize capital and service costs favors non-conventional business models in Spain over traditional capital-intensive purchasing and service models. Vendor-customer engagement over 10 to 15 years includes a broad range of value-adding services not limited to in-time renewal and procurement of new equipment. Equipment vendors and multi-vendor service providers are improving their solutions designed to provide a long-term partner-based service model with a commitment to outcomes and a risk-sharing component. This study presents the addressable market for medical imaging Managed Equipment Services (MES) and Multi-vendor Services (MVS) in Spain. The research service also discusses case studies, market opportunity, the competitive landscape, along with growth opportunities and companies to action. Thu, 2 Feb 2017 00:00:00 +0000 European Next-generation Sequencing Services Market, Forecast to 2023 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MCE8-01-00-00-00 The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: Revenue Forecasts Regional Market Dynamics Market Share Analysis and Top Countries Key Trends and Growth Opportunities Game-changing Companies Disruptive Technologies and Business Models Disruptive technologies in NGS are revolutionising the healthcare industry. Launch of high-throughput sequencers has set new service standards, with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis, and Sanger, propelling the demand for NGS services across areas such as human genetics, plant and animal biotech, agriculture, food and drug safety, and forensics. The European NGS services market is forecast to grow at a CAGR of 15.4% from 2016 to 2023 to reach $605.0 million by 2023. A relatively slow adopter of the technology, Europe now contributes to roughly a third of the global NGS services market size. Government-backed large-scale projects in the region such as the 100,000 Genomes Project of the United Kingdom (UK) and France Genomic Medicine Plan 2025 are poised to bring NGS to the forefront. Industry stakeholders are adapting to current market needs and aligning services with growth opportunities in research and clinical applications. The research service explores current industry trends and market response to the growing sequencing demand. The NGS services market in Europe has been comprehensively studied to understand the core value proposition of game-changing service providers. Industry-wide collaborations, focusing on diversified applications and value-added services, have also been discussed. The study provides an overview of the regional market dynamics focusing on key disruptive factors affecting market growth. The regional market is further segmented and market attractiveness of top countries has been studied. Market size estimations have been provided for Germany, United Kingdom, France, Spain, Italy, and Rest of Europe. Detailed coverage of NGS services market in Germany, UK, and France has been included. Drivers and restraints have been provided for a comprehensive time-bound assessment of the factors influencing the market paradigm. The study also reveals growth opportunities focusing on market needs across diversified application areas. The base year for the study is 2016, with the forecast period being 2017 to 2023. Key Questions this Study will Answer: How is the market attractiveness for NGS services growing over the years? What is the future market potential? How is the $1000 cost per genome milestone distressing market paradigm? What are the factors driving NGS services demand? What are the disruptions affecting the value chain equilibrium? What will be the focal areas on application-based services? Which are the service lines with maximum growth potential? How are the new technology trends impacting service providers? Which are the game-changing companies at work? What are the strategic levers to stay on the growth trajectory? How is the changing economic scenario affecting the regional market? Which are the key markets in Europe?--BEGIN PROMO--

Recent technological advancements in high-throughput sequencing are shifting the industry paradigm. Continued reduction in price per genome advertently impacting the market by increasing scale of sequencing projects. Launch of high-throughput sequencers setting new service standards with focus on superior coverage and accuracy. Low-cost and quick turnaround features have amplified NGS uptake as an alternative to traditional methods such as microarray, capillary electrophoresis and Sanger, propelling demand across industries- Human Genetics, Plant & Animal Biotech, Agriculture, Microbiome, Food & Drug Safety, Forensics.

KEY QUESTIONS THIS WILL ANSWER?

  • How is the market attractiveness for European NGS Services growing over the years? What is the future market potential?

  • Which are the game changing companies at work? What are the strategic levers to stay on the growth trajectory?

  • How is the changing economic scenario affecting the regional market? Which are the key markets in Europe?

Thu, 2 Feb 2017 00:00:00 +0000
Innovations in Disease Inspection and Diagnosis http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-10-00-00 This edition of the Medical and Diagnostic Imaging TOE depicts technology trends in disease inspection and diagnostic imaging markets, covering key IP trends and innovation profiles in the areas of: development of portable ultrasound scanner systems for low-income setting and remote areas, tetrahertz radiation for cancer diagnosis, cardiac mapping systems that is 10 times faster than conventional arrhythmia detection systems, and development of systems that use augmented reality platforms for surgical planning. Insights on future growth prospects for each of the innovation spotlight is also depicted along with the industry interactions. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Wireless ultrasound scanning systems, portable ultrasound, tetrahertz radiation, cardiac mapping system, augmented reality, surgical planning, conventional arrhythmia detection systems Fri, 27 Jan 2017 00:00:00 +0000 Recent Advances Enabling Enhanced Management of Neurological Disorders http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-37-00-00 Neurological disorders constitute a significant portion of current patient problems, which require better targeted therapeutics. At present there are a plethora of different technologies that will enable early detection of a range of neurological disorders. In this issue of Genetic Technology TOE, a comprehensive overview of point of care diagnostics as well as related biomarkers that will escalate the capability of developing novel therapeutics is presented. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Point of care, neurological disorders, Alzheimer's Disease, magnetic resonance imaging, blood biomarkers Fri, 27 Jan 2017 00:00:00 +0000 The Future of the United States http://www.frost.com/prod/servlet/sublib/display-report.do?id=NEE6-01-00-00-00 Frost & Sullivan's research service on The Future of the United States offers a comprehensive analysis of the Mega Trends that will impact American citizens and businesses through 2025. In this research, Frost & Sullivan's expert analysts highlight the imminent challenges and opportunities for growth stemming from the following trends: Social, Higher education, Politics, Industry, Health, wellness and wellbeing, Urbanization, Infrastructure, Mobility, Energy, Security and defense, Economics, Connectivity, Smart is the new green The study also offers strategic recommendations and predictions backed by relevant facts and statistics.--BEGIN PROMO--

Market Overview

Collaboration will define both personal and professional lives

Over the next 10 years, several social, technological, political and economic forces will reshape the business and lifestyle patterns of society in the United States. As Millennials age into management roles and government positions, they will wield significant influence on the American community. Consequently, organizations will re-prioritize competitive dimensions in order to adapt to changing customer dynamics.

Connectivity will penetrate industries and daily life through the Internet of Things. Cities will invest in smart technologies to forge new avenues for commerce and collaboration. This collaboration will lead to greater asset sharing, enhanced inter-business partnerships and strengthened employer-employee relationships. Subsequently, cybersecurity will emerge as a critical point of focus and technologies will become more proactive, adaptive and collaborative to protect against new risks. In spite of several challenges such as mounting student debts and aging infrastructure, the evolution of smart cities, advances in security technology and new jobs created by automation will revive the American dream.

Thu, 26 Jan 2017 00:00:00 +0000
Digitalization in Healthcare: Emergence of Digital Health Portals http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297252585 THE WIDESPREAD ADOPTION OF INFORMATION AND COMMUNICATION TECHNOLOGY (ICT) TOOLS AND APPLICATIONS IS TRANSFORMING ALMOST ALL ASPECTS OF INDUSTRIES, AND THE HEALTHCARE SECTOR IS NO EXCEPTION. Wed, 25 Jan 2017 00:00:00 +0000 CEOs Perspectives on Growth, Innovation, and Leadership in the Americas, 2016 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K186-01-00-00-00 Economies across the Americas are undergoing intense disruption. Digital transformation, competitive complexities, and changing customer demands are fostering new business models and strategic responses. This offers visionary CEOs the prospect of reshaping the business landscape and accelerating unique growth and innovation opportunities. Frost & Sullivan's annual survey of CEOs Perspectives on Growth, Innovation, and Leadership in the Americas, 2016 offers insights into how business leaders are dealing with this volatility and future-proofing their growth. About 75% of survey respondents cite revenue growth as their top growth objective over the next five years. They are adopting a variety of strategies to drive this agenda, even as they grapple with a volatile economic environment characterized by rapid and widespread technological transformation. The digital transformation of their business ecosystems highlights the need for new alliances and partnerships. While more than 40% of CEOs believe that they will rely on strategic partnerships to drive their organizations growth in the next three years, more than half acknowledge that they lag behind in effectively implementing such strategies. Rapidly changing customer behavior and demand, the growing importance of global connectivity and Big Data/intelligent data analytics, and the increasing relevance of new business models are also themes that have been discussed by CEOs in the survey. What are the ways in which organizations are responding to this environment? What are the complementary strategies they are adopting? Which best practices are fostering growth? Who are the disruptive innovators that are embracing and creating new opportunities? Today, disruptive innovators have transformed almost all industries across the global business landscape. Companies that do not embrace this disruption and fail to focus on innovation and growth, integrate new business models, and align with customer needs will find themselves increasingly marginalized. Key Questions the Study will Answer: What are the key growth objectives for organizations over the next five years? Are companies achieving their growth objectives? If not, what is holding them back? What are the top 10 growth opportunity themes for the future and which ones are organizations most likely to leverage? Which major strategies have driven maximum growth for organizations in the past three years and which strategies are organizations most likely to rely on to drive growth in the next three years? In what direction are stakeholder expectations evolving and what are some of the strategic responses that organizations are adopting to address these demands? What do organizations identify as being their most significant external and internal challenges? How do companies rate their growth and innovation performance? Which top technologies, Mega Trends, and business models have the potential to disrupt organizations? Which companies are identified as the most disruptive industry innovators? Wed, 25 Jan 2017 00:00:00 +0000 CEOs Perspectives on Growth, Innovation, and Leadership in Asia, 2016 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K15B-01-00-00-00 Asian economies are in the midst of intense disruption. Digital transformation, competitive complexities, and changing customer demands are fostering new business models and strategic responses. This offers visionary CEOs the prospect of reshaping the business landscape, and accelerating unique growth and innovation opportunities. Frost & Sullivan's annual CEOs Perspectives on Growth, Innovation, and Leadership in Asia, 2016 is an in-depth survey of business leaders from a wide cross-section of industries, with the overarching themes of growth, innovation, and leadership. It offers insights into how Asia's business leaders are tackling this volatility and future-proofing their growth. Revenue growth is the number 1 growth objective for CEOs over the next five years. Organizations, however, cite growth strategy implementation as a critical challenge. The CEO survey reveals the areas in which CEOs and business leaders need to improve their performance to steer a course of growth amidst increasing competitive pressures. Digital transformation is highlighted as a dominant growth, innovation and leadership catalyst over the next five years. However, the CEO survey indicates that the speed of technology change represents a real and immediate challenge, while also revealing the strategies CEOs are employing to drive maximum gains from digital disruption. Growth, competition, technology advances and changing stakeholder demands are germinating new business models. However, respondents indicate difficulties in integrating and strategically executing new business models. The CEO survey details some of the key emerging business models and evaluates whether companies have been able to effectively integrate these new business models into their organizations to drive growth. Disruptive innovators have transformed virtually every industry across the global business landscape. Organizations that do not embrace this disruption, fail to focus on innovation and growth, integrate new business models, and align with customer needs will find themselves increasingly marginalized. Frost & Sullivan's CEO s Perspectives on Growth, Innovation, and Leadership in Asia, 2016 provides vital insights into the ways organizations are strategically responding to this environment. It spotlights emerging technologies, Mega Trends, and business models that are creating unparalleled opportunities for sustained growth, disruptive innovation, and visionary leadership. Key Questions the Study will Answer: What are the key growth objectives for organizations over the next 5 years? Are companies achieving their growth objectives? If not, what is holding them back? What are the top ten growth opportunity themes for the future and which ones are organizations most likely to leverage? Which major strategies have delivered the most growth to organizations in the past three years and which strategies are organizations most likely to rely on to drive growth in the next three years? In what direction are stakeholder expectations evolving and what are some of the strategic responses that organizations are adopting to address these demands? What do organizations identify as being their most significant external and internal challenges? How do companies rate their growth and innovation performance? Which top technology, Mega Trends and business models have the potential to disrupt organizations? Which companies are identified as the most disruptive industry innovators? Tue, 24 Jan 2017 00:00:00 +0000 Innovations in Medical Devices in Bioelectronics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D852-00-0D-00-00 The latest issue of the Medical Device TOE showcases innovations in the field of bioelectronics. Typically, the products are miniature implantable devices or patch-based systems that can deliver micro-currents to the target neural system. Technologies that have been showcased in this edition use electrical pulses to stimulate neural cells to managed and treat conditions such as migraines, hypertension, inflammatory disease, and obesity. The Medical Device TechVision Opportunity Engine (TOE) analyzes and reports on new and emerging technologies and advances in R&D; product development; and regulatory matters related to neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Keywords: Bioelectronics, neurostimulation, implantable devices, neuromodulation Fri, 20 Jan 2017 00:00:00 +0000 Cellular Therapy Innovations in Asia http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-36-00-00 This edition of Genetic Technology TOE depicts trends in cellular therapies across Asia. Cell therapies enable to address a broad spectrum of health concerns associated to multiple disease areas. The corresponding patent scenario for stem cell therapeutics is depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Cell therapy, cellular therapy, mesenchymal stem cells, T-cell therapies, regenerative medicine, stem cell therapeutics Fri, 20 Jan 2017 00:00:00 +0000 Global Precision Medicine Growth Opportunities, Forecast to 2025 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0E6-01-00-00-00 Precision medicine aims to integrate personalized health data both from direct (quantifiable) and indirect (quantifiable) sources probing the deepest mysteries affecting individual health and well-being. Rising pressures to decrease healthcare cost globally, emergence of value-based reimbursement models, and healthcare digitization trends are transitioning the treatment model from One-size-fits-all to stratified and outcome-based targeted therapies called precision medicine. In the past few decades, our scientific knowledge and technological advancements around genomics has increased exponentially, making cost and time no longer a barrier for population-level genome profiling. Integration of these genomic and lifestyle data into clinical workflow to derive deeper insight into genetic and chronic deceases is unique to the precision medicine concept. However, the precision medicine concept is a nascent one that needs further refinement at fundamental levels with incremental progress towards more effective and targeted drugs that are precisely accurate in reducing the treatment uncertainty, to ultimately revolutionize the care delivery model in the long run. Also, the current legal and ethical frameworks both at global and regional levels were built with a very different generation of medical products and practices in mind and raise some serious challenges for the revolutionary concept of precision medicine practice. Research Scope: The research service analyzes the key building-blocks for precision medicine ecosystem to provide strategic imperatives and growth opportunities for key industry participants. The study also captures both global and regional flavours for precision medicine market opportunity realization such as market projections, drivers and restraints, country readiness index, and major government and commercial initiatives. Finally, the study provides live case studies and innovative business models for leading select companies in the precision medicine space. Key Questions This Study Will Answer: What is Precision Medicine and its impetus for the healthcare industry? What does the precision medicine ecosystem look like? Who are the key stakeholders and what are their roles? What are the current gaps in the precision medicine ecosystem and how can these be filled by industry partners? How big is the precision medicine market? What are the growth opportunities by major therapeutic areas, market segments, and technologies? What are the major market drivers and restraints for the precision medicine market and what are their use cases? Which countries demonstrate the highest growth opportunities for precision medicine? How are the regulatory and reimbursement landscapes evolving across these countries? What are the most promising business models emerging in the healthcare space to enable precision medicine practice? What are the strengths of my business against competition? Are these strengths sustainable over the next 5-10 years? What winning and losing strategies can be gleaned from the existing market case studies and companies to watch? Wed, 18 Jan 2017 00:00:00 +0000 Diagnosing the State of Medical Imaging in the United States: Perspectives from RSNA 2016 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297227474 Two months ago, Chicago, the windy city, played host once again to the Radiology Society of North America (RSNA) conference. Like previous years, the conference brought together industry participants, regulators, academics, medical professionals. Mon, 16 Jan 2017 00:00:00 +0000 Technologies Enabling Precision Medicine-based Drug Discovery http://www.frost.com/prod/servlet/sublib/display-report.do?id=D951-00-0D-00-00 This edition of the Drug Discovery TOE assesses the potential of drug discovery technologies that are enabling the era of precision medicine. Customization of microfluidic properties for the development of organ on a chip technologies are improving target identification and validations extensively. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Microfluidic system, humanization, kinase inhibition, single cell research, selective inhibition, target identification Fri, 13 Jan 2017 00:00:00 +0000 Recent Advances in Immunology http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-35-00-00 This edition of Genetic Technology TOE depicts trends across immunology. The recent findings in genetics are likely to support novel approaches toward the management of immunity and may have a significant impact across target discovery in the near future. The corresponding patent scenario is depicted, along with the industry interactions. . The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Immunology, genetic technologies, genetics, amyloid-beta peptide, noninvasive vaccination, immunity assessment, vaccination efficacy, immune response Fri, 13 Jan 2017 00:00:00 +0000 Future of Behavioral Healthcare Paradigms, Forecast to 2022 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K12C-01-00-00-00 The annual global cost of mental illnesses is set to rise to a whopping $6 trillion in 2030, from $2.5 trillion in 2010. Furthermore, the global treatment gap in 2004 for disorders such as depression and anxiety was more than 50% (half of the patients went untreated). Unfortunately, the situation has still not changed significantly. A growing body of evidence suggests that mental and physical health are fundamentally linked, indicating the need for holistic treatment approaches to include behavioral health for better patient outcomes. This research service analyzes the behavioral health market, its drivers such as the emergence of digital health technologies and gradually improving awareness, as well as restraints such as reimbursement issues and cultural stigma which prevent its growth. New focus areas in the care continuum are prevention (recognizing early symptoms and preventing worsening of the disease) and recovery (ensuring treated patients become productive members of the society). This study also assesses how treating the patients physical as well as behavioral health issues together will become the new model of integrated care delivery. Thu, 12 Jan 2017 00:00:00 +0000 Custom Procedure Trays and Packs in Western and Eastern Europe, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC7C-01-00-00-00 This research service presents a detailed analysis of the European Custom Procedure Trays and Packs (CPTP) market. It provides an in-depth analysis of the market size, revenue forecast, overall as well as by surgical custom procedure trays and packs and minor procedure trays and packs and by packaging type (boxes, wraps and moulds). The surgical segment comprises nine specialty areas cardio-vascular; Ear, nose, and Throat (ENT); general and abdominal surgery, including laparoscopy; obstetrics and gynecology; neurosurgery; ophthalmology; orthopedics; plastic surgery; and urology packs and trays. The minor procedures segment comprises eight specialty areas angiography; antiseptic skin preparation; catheterization; hemodialysis; perfusion and IV therapy; regional anesthesia, suturing; and wound care packs and trays. The regional scope includes Western Europe (Germany, United Kingdom, France, Spain, Italy, Benelux, and Scandinavia) Eastern Europe (Bulgaria, the Czech Republic, Hungary, Poland, and Romania). Tue, 10 Jan 2017 00:00:00 +0000 Advancements in Microbiome and Genetics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-34-00-00 This edition of Genetic Technology TOE profiles trends across microbiome and genetics advancements. Microbiome science is an emerging arena that has impacted various segments. Skin health, gastrointestinal health, and supplemental health are all areas that would truly benefit from the products that can activate the human microbiome. Microbiome modulation using drugs could stimulate latent mechanisms to work effectively within the human body. Once these parameters are stimulated, enormous health benefits can be achieved. The TOE depicts the corresponding patent scenario, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Microbiome, genetics, sampling technology, gastrointestinal biomarkers, functional genomics, microbiome-based treatments, lactose intolerance, genetic testing Fri, 6 Jan 2017 00:00:00 +0000 Potential Impact on Health IT as US Adjusts to Republican Sweep in Election 2016 http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297194637 The stunning outcome of the 2016 presidential election has left us long on questions and short on detail as to what this decisive win portends for healthcare markets in general and health IT specifically. Mon, 2 Jan 2017 00:00:00 +0000 Western European Molecular Diagnostics Market, 2015 Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC62-01-00-00-00 Across the In vitro diagnostics Segment , including research and further upcoming disruptive technologies Across the Life Sciences landscape, including research tools, clinical diagnostics and pharma, disruptive technologies transform the complete the Healthcare decision making , and diagnostics trend . However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside of their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics Companies who fail to capitalize on opportunities presented through emerging trends and disruptive new business models become late entrants in a market that generally before redundancy from me-too products occurs and takes market share. This report is an elaborate structure of the European Healthcare system , which is supporting the growth of Molecular diagnostics , the reimbursement strategies and policies promoting the acceptance of MDx assays across application , This information would be suitable to understand the current need and the diagnostics style adaptation among the patient population for better outcome and clinical decision making. Specific challenges shared in this report include shifting payment landscape (business models) who pays for services, challenge monetize Innovative Therapeutics & Molecular Diagnostics to align with Value based Care Models Mon, 2 Jan 2017 00:00:00 +0000 Recent Advances in Genomic Techniques across the United States - Genetic TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D758-00-33-00-00 This edition of Genetic Technology TOE profiles trends in genomic techniques across the United States. The corresponding patent scenario is depicted along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Genomic techniques, sequencing tool, gene networks, molecular tags, genetic marker-based assay, metastatic cancer, anti-sense therapy, KRAS Mutations Fri, 30 Dec 2016 00:00:00 +0000 Key Innovation Profiles in Medical and Diagnostic Imaging in UK - Medical and Diagnostic Imaging TOE http://www.frost.com/prod/servlet/sublib/display-report.do?id=D861-00-0F-00-00 This edition depicts medical and diagnostic and imaging innovations in UK. Quantitative reading software, medical scanner to augment 3D bio-printing, radiowave radar technology for imaging breast cancer, non-invasive imaging approach for detection of prostate cancer, oxygen-enhanced MRI for lung diseases, intra-cellular ultrasound imaging, PACS system for National Health Services (NHS) and optical with gamma combination imaging systems as an hybrid imaging modality have been profiled. Insights on future growth prospects for each of the innovation profiled is also provided along with the industry interactions. Medical and Diagnostic Imaging TechVision Opportunity Engine (TOE)'s mission is to analyze and report new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, Ultrasound and X-ray. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image guided surgery and healthcare IT related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered. The Health and wellness cluster covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies and imaging technologies and platforms. Keywords: Quantitative image reading, 3D bio-printing, radiowave radar technology, oxygen-enhanced MRI, intra-cellular ultrasound imaging, PACS system, hybrid imaging, optical and gamma combination imaging systems Fri, 30 Dec 2016 00:00:00 +0000 Israeli Technologies Impacting the Global Medical Sector http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A4-01-00-00-00 Over the past two decades, Israel had risen to be an global medical devices innovation hub, reinforcing its position as one of the major contributors to the growth of the innovations in the global medical devices sector. With a plethora of scientific resources, ease of conducting clinical research studies, globally competitive intellectual portfolio management practices, access to global investor networks, inclusion of a collaborative work culture and extensive knowledge in commercializing cutting-edge technologies, Israel is one of the countries that has found profound success in devising safe and effective therapies for addressing debilitating medical disorders. This research service evaluates the commercial impact and stakeholder strategies for top medical devices technologies in Israel, which include neuroprostheses, X-eluting stents, smart pills, surgical robotics, surgical lasers, and neuromodulation therapies. The following questions are answered in this report: 1. Who are the various innovation stakeholders (such as technology developers, clinical researchers and investors) in Israel that enable its development as a global innovation hub for medical devices? 2. What is the intensity of commercialization efforts that are happening across major cities (regional innovation hubs) of Israel namely, Tel Aviv, Jerusalem, Haifa, Yokneam, Ra'anana, Herzliya, Beer'Sheva, and Cesaerea? 3. Identifying the competencies of regional innovation hubs in Israel to sustainable innovate cutting-edge medical device technologies. 4. What are the strategic gaps that exist in the existing innovation ecosystem in Israel, and how commercial opportunities available for innovators in both Israeli and global players span out near-to-far term investments in Israel medical devices sector? 5. What are the strategic recommendations of analysts to stakeholders when evaluating early investment opportunities in Israel's medical devices sector? 6. Gather additional knowledge and recommendations in evaluating commercial partnership initiatives such as cross-selling agreements, in-organic growth initiatives such as acquisition or merger of Israeli firms, and regional/international collaborations on clinical trials. 7. How is the patent landscape in Israel for top medical device technologies? Why global companies hold most regional patents, and Israeli-based firms holding patents in matured medical device markets (especially in the USA and Europe)? Fri, 30 Dec 2016 00:00:00 +0000 3D Printing for Healthcare Applications http://www.frost.com/prod/servlet/sublib/display-report.do?id=D75D-01-00-00-00 3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher s podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry. Fri, 30 Dec 2016 00:00:00 +0000 MGMA conference reveals range of medical practice struggles in optimizing IT-enabled care http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297188466 Frost & Sullivan was in attendance at the MGMA conference held in early November in San Francisco. This is an annual conference primarily targeted to medical practice stakeholders including CXOs, administrators, physicians, nurse practitioners, and also healthcare IT vendors enabling value-based care for medical practices. Thu, 29 Dec 2016 00:00:00 +0000 Electronic Skin - Advancements and Emerging Opportunities http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A0-01-00-00-00 Electronic skin, otherwise known as e-skin or artificial skin is an ultrathin electronic material developed by integrating electronic devices on flexible and stretchable substrates. E-skin is an emerging and an advanced technology which is primarily intended for health monitoring and medical applications, such as measuring and sensing of internal vital sign activities in the body. E-skin has created footprint in consumer electronics and robotics markets. In the consumer market, e-skin is expected to replace existing body worn wearable devices, thus leading to creation of a new user interface device for controlling external electronic devices. E-skin has the potential to have high impact on robotics applications due to their ability to provide sense of touch. The technology and innovation report discusses about emerging opportunities in e-skin. It captures advancements and impact of current and future applications. Modules covered in the report include: Technology Status and Segmentation Application Landscape Key Innovations and Impact on Key Application Segments Patent Assessment and Funding Scenario Technology Roadmap and Emerging Opportunities Key Questions for Strategy Planning Thu, 29 Dec 2016 00:00:00 +0000 Utility of Video Telemedicine Solutions for Strengthening Healthcare in Africa http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297183302 Frost & Sullivan s individual analysis, Enabling eHealth Technology in South Africa, Kenya, and Ghana , indicates that in Africa, governments and providers are adopting tele-healthcare tools (such as video telemedicine) in order to facilitate easily accessible healthcare to remote and rural regions. Tue, 27 Dec 2016 00:00:00 +0000 Trends Affecting the Healthcare IT Market in Western Europe http://www.frost.com/prod/servlet/sublib/display-market-insight.do?id=297183329 Frost & Sullivan s individual analysis, Western Europe Hospital Information Technology Outlook, 2016 2020 , indicates that the Healthcare IT market of Western Europe (covering nations such as the United Kingdom, Germany, France, Italy, Spain, Belgium, the Netherlands, Luxembourg, Sweden, Denmark and Norway) is undergoing tremendous changes with the advent of emerging digital health technologies Tue, 27 Dec 2016 00:00:00 +0000 Global Care Assistance and Automation Robots Market, Forecast to 2021 http://www.frost.com/prod/servlet/sublib/display-report.do?id=K0F6-01-00-00-00 The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime reason for successive adoption of care robots in the healthcare industry. Human-robot collaborations are expected to achieve breakthrough revolution in hospital and home-care settings. From carrying daily products such as medical waste, linen, lab reports, and meals to dispensing medicines and IV supplies, robots have the capability to significantly automate and impact hospital workflows, thereby improving productivity and, ultimately, quality of care. This study includes a detailed description of care assistance and automation robots and their sub-segments: daily care and transportation, telepresence and rehabilitative, pharma automation, and exoskeleton robots. The research also consists of detailed analysis of the current estimated market (2016) and market forecasts (2017 2021) of care assistance and automation robots and the sub-segments, description of various types of companies in this market, the future potential growth scenarios, and price points of each sub-segment. The study wraps up with key conclusions and a brief snapshot of strategies for succeeding while building a robots-for-hospital business model. Key objectives address the following questions: What are the current use cases of care assistance and automation robots within the healthcare sector? What barriers and challenges are care robots currently facing towards adoption? What are the market drivers? What are the current use cases for robots from various sub-segments of the care assistance and automation market? What will be the care assistance and automation robots market scene in the next five years? What are the market estimations and projections? Who are the current participants in the market ecosystem with solutions for varying applications within the healthcare industry? Mon, 26 Dec 2016 00:00:00 +0000 APAC Home Health Monitoring Market, Forecast for 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=P918-01-00-00-00 APAC s home health monitoring market is set to generate nearly $2.2 billion by 2020. Local and international vendors should identify the long-term market progression and opportunity within home monitoring for both acute and chronic care in this region. APAC is shifting from centralized to decentralized models due to the need for efficient care delivery models. A combination of technological advances and regulatory overhaul across the region will enable innovative care delivery models, especially for managing chronic and life-style related diseases that will drive the demand for platform-based home monitoring solutions over the next five years. There is a concomitant increase in demand for remote patient monitoring (RPM) devices in the home but the adoption has not been as strong. Healthcare stakeholders in this region have also formed consortiums and are investing in pilots to generate data to build a funding model. Collaborated initiatives, such as Australia s National Telehealth Home Monitoring, South Korea s National Telehealth Demonstration Project, or Singapore s National Cardiac Monitoring are set to expand the market for home health monitoring. Technology-savvy societies like Japan, Singapore and Australia are already investing in population-level pilots while private healthcare providers in emerging markets like India are introducing platform-based home health solutions to niche customer segments. Integrated home monitoring platforms include devices offered through extremely flexible and lucrative payment plans, while money is made on clinical services provided through the data captured. The market is shifting focus from stand-alone devices to comprehensive remote patient monitoring platforms for end-to-end chronic disease management. Failure to accept the transformation by changing the current business model will result in inability to monetize, though the market is packed with opportunities yet to be explored. Vendors will struggle choosing the right business model to push their products to the market. This study analyzes the APAC market for home monitoring devices, sensors, wearables and mHealth apps as well as successful business models in this space and some innovative collaborations. Key Questions This Study will Answer What is the current state of home monitoring in APAC? How will it evolve until 2020? What are the most promising applications of home monitoring across therapeutic areas? What are the current technology and usage trends in the market? How will these evolve until 2020? How will the structure of the market change with time? What are the current sales channels and will these changes to offer better access in the future? What are the business models that are disrupting the market? Mon, 26 Dec 2016 00:00:00 +0000 eHealth to Strengthen Delivery of Care for Non-Communicable Diseases in Africa http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC78-01-00-00-00 eHealth to Strengthen Delivery of Care for Non-communicable Diseases in Africa Narrowing the Accessibility Gap through Partnerships, Growth Opportunities Created by Increased Disease Prevalence This study aims to analyse the eHealth market in Africa and its application in the mitigation of non-communicable diseases (NCDs). The major focus is on market trends (mHealth, wearables, and video telemedicine) and regional trends (Southern Africa, East Africa, West Africa, North Africa, and Indian Ocean Islands), focusing on the main competitors in each region. The major NCDs include various types of cancer, diabetes, respiratory diseases, and cardiovascular diseases. Mental health diseases are also noticeably growing in the continent. Africa s healthcare systems continue to struggle to adequately cater to the growing population, worsened by a high incidence of poverty in most parts. Low-resource communities bear the brunt of NCDs, as treatment is often costly. This then results in an increase in premature deaths as several individuals go untreated either due to lack of finances or late detection. However, as the economic growth rate is on an upward trajectory in many nations, the need for the improvement of healthcare facilities, IT systems, and infrastructure becomes more apparent. As the populations become more economically enabled, changes in lifestyle begin to be noticed. Smoking, excessive drinking, physical inactivity, and excessive salt/sodium intake are some of the negative lifestyle activities associated with prosperous and prospering nations, and NCDs. Also, the disease burden continues to increase for both communicable and non-communicable diseases, requiring new technology to manage populations. This study looks at the market leaders in each African region and how East Africa is leading the revolution as well as Southern Africa, with a focus on mHealth, wearables, and video telemedicine. These regions are led by Kenya and South Africa, respectively. The disease categories in this study are cardiovascular, cancer, diabetes, and respiratory the 4 largest NCD classes, responsible for over 80% of the NCD deaths around the globe. The main drivers and restraints of the market are highlighted in this study along with cross-country healthcare and IT trends. It proposes the growth opportunities available for companies and other eHealth stakeholders in implementing and improving eHealth in Africa as well as future perspectives. Key Questions This Study Will Answer: 1. Why is eHealth important for Africa? 2. What are the main eHealth markets, segments, and regions? 3. What are the main drivers and restraints for the eHealth market in Africa? 4. What are the utilities of eHealth in mitigating non-communicable diseases in Africa? 5. What are the growth opportunities in the African eHealth markets? 6. Which key companies are set to lead the market for eHealth? Thu, 22 Dec 2016 00:00:00 +0000 Innovations in Implantable Electronics http://www.frost.com/prod/servlet/sublib/display-report.do?id=D7A3-01-00-00-00 The technology and innovation study on implantable electronics captures active implantable medical devices used for support of debilitating function in the human body or to completely replace the function of the diseased organ. The segments covered include: cochlear implants, retinal implants, implantable continuous glucose monitoring (CGM), implantable infusion pumps, cardiovascular implantable electronic devices, and implantable neurostimulation. Recent innovations and key innovators are captured under each segment. The study also covers reimbursement scenario of each of these devices in North America, Europe and Asia-Pacific. Regulatory framework and insurance coverage are considered to be the key factors that can lead to the successful growth of the implantable electronics market. Global patent scenario and key factors (drivers and challenges) influencing adoption have been identified. To aid C-level executives in strategic planning, technology convergence and growth opportunities (based on varied criteria such as business models and new capabilities) are captured in the study. Thu, 22 Dec 2016 00:00:00 +0000 African Pharmaceuticals Market, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC24-01-00-00-00 The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest reservoir of infectious diseases, particularly malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), besides frequent outbreaks of polio, meningitis, cholera, pandemic influenza, yellow fever, measles, hepatitis, and tetanus. With the increasing adoption of Western lifestyle in Africa, there has been a paradigm shift in the burden of illness towards non-communicable diseases (NCDs), driving the demand for chronic prescription drugs. While continuing to suffer from infectious and parasitic illness, lifestyle diseases such as cardiovascular diseases, diabetes, and cancer will witness high growth rates throughout the forecast period. The World Health Organisation predicts that the proportional contribution of NCDs to the healthcare burden in Africa will rise by 21% through 2030. The growing middle class is a key driving force for pharmaceuticals spending. Limited affordability of governments and the general population for healthcare and pharmaceuticals and a high reliance on donor funding will be the major market restraints.--BEGIN PROMO--


Africa is in a transition phase, on its way to achieving adherence to global standards, such as the WHO pre-qualification for manufacturing. Local production is regarded as a key strategy for sustained access to quality-assured medicines for the long term. The regulatory environment for manufacturing in regions such as East Africa seems to grow rapidly, owing to regional harmonisation. Healthcare coverage is expected to expand to a greater proportion of the population through National Health Insurance (NHI) initiatives, as well as through memberships with private health insurance providers, particularly among the emerging middle class.

South Africa remains as the best established region for pharmaceutical manufacturing in sub-Saharan Africa. However, the local manufacturing markets in East and West Africa are relatively well developed and positioned to grow. A bulk of Africa-based pharmaceutical companies that are developing medicines have simple formulations and mixtures, which are easy to do. Technology transfer is paramount to developing the manufacturing sector in Africa, particularly as the disease burden is changing. There is a paradigm shift coming from the lower end to the higher end of adoption of complex formulations, in line with treatment guidelines, especially in HIV and AIDS and NCDs.

This research service presents findings on 2 fast-growing pharmaceutical markets in sub-Saharan Africa: Kenya and Nigeria. A brief competitive overview, along with the pricing and regulatory environment is provided for each country. Revenues and growth forecasts, insights on market dynamics, and drivers and restraints for the pharmaceutical markets of Kenya and Nigeria are covered. Market segmentation is done based on products (prescription—branded and generic and consumer care/over the counter) as well as therapeutic areas (haematology, oncology, men's health, central nervous system (CNS), women's health, diabetes, cardiovascular, dermatological, gastrointestinal, cough and cold, nutritional, analgesics, and anti-infectives).The study also provides the business opportunities and strategic recommendations for the pharmaceuticals market.

Wed, 21 Dec 2016 00:00:00 +0000
Funding Analysis of Emerging Microelectronics Technologies http://www.frost.com/prod/servlet/sublib/display-report.do?id=D79B-01-00-00-00 The objective of this research service is to cover the funding landscape of key emerging microelectronics technologies, viz., wearables, printed and flexible electronics, and brain-computer interface (BCI). Wearables have experienced a lot of interest from diverse fields and there have been a lot of developments worldwide. Various established companies and start-ups are constantly innovating to gain a foothold in this market. Flexible and printed electronics has shown a lot of potential to enable low cost mass manufactured products using printing technologies. However, manufacturing bottlenecks has hindered the adoption of the technology. It is expected that these challenges will be resolved in the near term as various companies are ramping up production to meet increasing demands. The research report covers funding initiatives from government, venture capital investment, and crowdfunding. It also covers key mergers and acquisition (M&As) activities and analyses its impact. The research report also captures key trends and technology roadmaps; it also assesses gaps in funding that needs to be addressed. Wed, 21 Dec 2016 00:00:00 +0000 Market Analysis of Emerging Cardiac Therapies in the United States and Western Europe, Forecast to 2020 http://www.frost.com/prod/servlet/sublib/display-report.do?id=MC02-01-00-00-00 The biggest challenge for emerging cardiac procedures is adoption barrier and reimbursement. The long-term clinical evidence gathered through clinical studies and the technological improvement in the product pipeline has addressed the adoption barrier and reimbursement coverage based on morbidity of the patients is the first step towards increased adoption. The market trends, revenue forecasts, and competitive trends for each of the four segments are discussed in detail. The research contains data about four of the emerging cardiac devices/procedures market. Cardiac Procedures developed conventionally was to address the cardiac condition. Today, most procedures and products developed are to address the ailment of the patients that cannot be supported with conventional procedures and devices. The market dynamics of these emerging procedures and devices are greatly determined the upcoming product launches and product pipeline. The report encompasses an overview of emerging cardiac therapies with key findings. The emerging trends and technologies in the interventional cardiac sector and its potential market dynamics are also discussed. The analysis provides a roadmap for companies in cardiac sector to understand the emerging cardiac technologies and help them to prepare and stay competitive for the changing landscape of cardiac surgeries. Regions include United States and Western Europe (Germany, France, Spain, Italy, and the United Kingdom). This report provides revenue forecasts, reimbursement trends, and top company profiles of key segments such as Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Repair (TMVR), Endovascular Aortic Repair (EVAR), and Left Ventricular Assisted device (LVAD). Key questions this study will answer: What are the technological evolutions in the cardiac procedures and how will they impact the overall cardiac sector? Which are the most promising technologies in the emerging cardiac therapies? How will the cardiac companies continue to exist through product innovations or inorganic growth? What are the regulatory challenges faced by the device manufacturers? Are the cardiac products offered today meeting customer needs or is additional development needed? Tue, 20 Dec 2016 00:00:00 +0000